SCHEMBL5774461

SCHEMBL5774461

Cc1noc(-c2ccccc2)c1/C=C/C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 9/20 0.52
IP6K2 Q9UHH9 9/20 0.52
IP6K3 Q96PC2 8/20 0.52
ALDH1A1 P00352 4/20 0.52
HTT P42858 2/20 0.52
GAA P10253 2/20 0.52
TBK1 Q9UHD2 1/20 0.52
LMNA P02545 1/20 0.52
RXRA P19793 1/20 0.48
NR4A1 P22736 1/20 0.48
RXRB P28702 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
BRD4 O60885 1/20 0.44
BRD2 P25440 1/20 0.44
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PTPN1 P18031 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LPAR1 Q92633 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774464 1.00 IP6K1 (0.52) IP6K1IP6K2IP6K3ALDH1A1HTT
SCHEMBL4676910 0.86 IP6K1 (0.58) IP6K1IP6K2IP6K3ALDH1A1HTT
SCHEMBL15239076 0.83 ALDH1A1 (0.43) IP6K1IP6K2IP6K3ALDH1A1HTT
SCHEMBL15239078 0.83 ALDH1A1 (0.43) IP6K1IP6K2IP6K3ALDH1A1HTT
SCHEMBL3982046 0.79 ALDH1A1 (0.46) IP6K1ALDH1A1BRD4BRD2MAPT
SCHEMBL1124487 0.77 GAA (0.49) IP6K1IP6K2IP6K3ALDH1A1GAA
SCHEMBL1124489 0.77 GAA (0.49) IP6K1IP6K2IP6K3ALDH1A1GAA
SCHEMBL5773258 0.76 ALDH1A1 (0.49) ALDH1A1GAALMNAMAPTKDM4E
SCHEMBL5773251 0.76 ALDH1A1 (0.49) ALDH1A1GAALMNAMAPTKDM4E
SCHEMBL1574 0.72 IP6K1 (0.45) IP6K1IP6K2IP6K3ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR IP6K1 729/4885IP6K2 866/4885IP6K3 253/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 IP6K1 396/4885IP6K2 570/4885IP6K3 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.